Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

Combination therapy is more effective for prostate volumes over 60 ml.

Finasteride may reduce prostate cancer risk.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Early balding may be a sign of future prostate problems.

Finasteride effectively reduces the need for surgery and urinary issues in men with BPH over the long term.

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Genetic variations may affect how well finasteride works for BPH patients.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Finasteride can help regrow hair in male pattern baldness.